UAL
77
3
CINF
31
3
BEN
28
3
PG
37
4
FCX
43
3
BWA
40
3
IPG
38
2
PHM
49
9
AMP
50
4
HSIC
53
2
ZION
65
6
PPL
49
4
TXT
46
4
EQIX
57
4
PLD
41
6
URI
40
7
EXR
39
2
UPS
60
4
AEP
61
2
DFS
70
2
UAL
77
3
CINF
31
3
BEN
28
3
PG
37
4
FCX
43
3
BWA
40
3
IPG
38
2
PHM
49
9
AMP
50
4
HSIC
53
2
ZION
65
6
PPL
49
4
TXT
46
4
EQIX
57
4
PLD
41
6
URI
40
7
EXR
39
2
UPS
60
4
AEP
61
2
DFS
70
2
Financhill
Back

Aritzia Vs. Blueprint Medicines Industry Stock Comparison

Buy
100

ATZAF
Aritzia

Last Price:
$46.20
Seasonality Move:
-1.14%
Sell
40

BPMC
Blueprint Medicines

Last Price:
$102.47
Seasonality Move:
5.27%
Buy
100
Aritzia (ATZAF) is a Buy

Is Aritzia a Buy, Sell or Hold?

  • The current Aritzia [ATZAF] share price is $46.20. The Score for ATZAF is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
  • ATZAF is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
40
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $102.56. The Score for BPMC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ATZAF Stock Price Chart

What is Aritzia's stock price today?

  • The Aritzia share price today is $46.20
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATZAF is experiencing slight buying pressure.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $102.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing selling pressure, which indicates risk of future bearish movement.

ATZAF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.61 Buy
Relative Strength Index (14 RSI): 73.84 Buy
Chaikin Money Flow: 641 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.64 - 41.38) Buy
Bollinger Bands (100): (31.71 - 37.93) Buy

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.85 Buy
Relative Strength Index (14 RSI): 63.82 Buy
Chaikin Money Flow: -913925 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.06 - 96.6) Buy
Bollinger Bands (100): (86.99 - 95.95) Buy

ATZAF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.93 Buy
20-day SMA: 38.68 Buy
50-day SMA: 35.27 Buy
200-day SMA: 31.38 Buy
8-day EMA: 42.63 Buy
20-day EMA: 39.59 Buy
50-day EMA: 36.71 Buy
200-day EMA: 32.15 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.93 Buy
20-day SMA: 91.76 Buy
50-day SMA: 93.83 Buy
200-day SMA: 96.87 Buy
8-day EMA: 94.89 Buy
20-day EMA: 92.92 Buy
50-day EMA: 92.72 Buy
200-day EMA: 91.71 Buy

Aritzia Earnings Growth & ATZAF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.61 per share, and an increase next year of $0.56 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $2.89 per share.

Aritzia Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):